Enliven Therapeutics

Enliven Therapeutics

Price & Volume

Stats

See more
52W Range
$14.78-$62.32
Market Cap
$3.4B
Shares Short
10M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$1.69

About

CEO
Mr. Richard A. Fair M.B.A.
CFO
Mr. Benjamin Hohl
Address
205 Park Road, Burlingame, CA, United States, 94010
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
65